Literature DB >> 8826027

Patient-administered sphenopalatine ganglion block.

E Saade1, G B Paige.   

Abstract

BACKGROUND AND OBJECTIVES: Pain resulting from head and neck cancer can be severe and difficult to manage. Avoiding hospitalization for as long as possible with a reasonable level of comfort requires a number of therapeutic modalities. The usefulness of self-administered sphenopalatine ganglion block was evaluated in a patient with lethal midline granuloma requiring large doses of morphine.
METHODS: A 30-year-old woman with intractable pain from lethal midline granuloma was taught to self-administer 4% lidocaine, 1.5 mL topically into each nostril three times per day.
RESULTS: A 3-month follow-up examination showed substantial pain relief and reduction in morphine requirement. No adverse side effects or complications developed.
CONCLUSIONS: In certain patients, sphenopalatine ganglion block can be effectively self-administered at home to manage chronic pain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8826027

Source DB:  PubMed          Journal:  Reg Anesth        ISSN: 0146-521X


  3 in total

Review 1.  Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review.

Authors:  Kwo Wei David Ho; Rene Przkora; Sanjeev Kumar
Journal:  J Headache Pain       Date:  2017-12-28       Impact factor: 7.277

2.  Home-based Application of Sphenopalatine Ganglion Block for Head and Neck Cancer Pain Management.

Authors:  Priti R Sanghavi; Bhavna C Shah; Geeta M Joshi
Journal:  Indian J Palliat Care       Date:  2017 Jul-Sep

3.  Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study.

Authors:  Joan Crespi; Daniel Bratbak; David Dodick; Manjit Matharu; Kent Are Jamtøy; Irina Aschehoug; Erling Tronvik
Journal:  J Headache Pain       Date:  2018-02-13       Impact factor: 7.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.